Juan Andres
Director/Board Member en AVANTOR, INC. .
Fortuna: 1 M $ al 31/03/2024
Cargos activos de Juan Andres
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| AVANTOR, INC. | Director/Board Member | 01/09/2019 | - |
| Independent Dir/Board Member | 01/09/2019 | - | |
Ring Therapeutics, Inc.
 Ring Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ring Therapeutics, Inc. engages in the development of a gene therapy platform. Its Anellovector platform provides tissue specifities benefitting from the inherent diversity of tropism afforded by the commensal virome. The company was founded in 2000 and is headquartered in Cambridge, MA. | Director/Board Member | - | - |
Historial de carrera de Juan Andres
Antiguos cargos conocidos de Juan Andres.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| EVELO BIOSCIENCES, INC. | Director/Board Member | 04/12/2019 | 20/11/2023 |
| Independent Dir/Board Member | 04/12/2019 | 20/11/2023 | |
| MODERNA, INC. | Chief Tech/Sci/R&D Officer | 01/08/2017 | 01/01/2023 |
| Corporate Officer/Principal | 01/01/2023 | 31/05/2023 | |
| NOVARTIS AG | Chief Tech/Sci/R&D Officer | 01/08/2005 | 01/06/2017 |
| Corporate Officer/Principal | - | - | |
| ELI LILLY AND COMPANY | Corporate Officer/Principal | 01/01/1987 | 01/01/2009 |
Formación de Juan Andres.
| Universida de Alcalá de Henares | Graduate Degree |
Estadísticas
Internacional
| Estados Unidos | 6 |
| Suiza | 2 |
| España | 2 |
Operativa
| Corporate Officer/Principal | 3 |
| Director/Board Member | 3 |
| Chief Tech/Sci/R&D Officer | 2 |
Sectorial
| Health Technology | 6 |
| Consumer Services | 2 |
| Process Industries | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 5 |
|---|---|
| ELI LILLY AND COMPANY | Health Technology |
| NOVARTIS AG | Health Technology |
| EVELO BIOSCIENCES, INC. | Health Technology |
| AVANTOR, INC. | Process Industries |
| MODERNA, INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
Ring Therapeutics, Inc.
Ring Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ring Therapeutics, Inc. engages in the development of a gene therapy platform. Its Anellovector platform provides tissue specifities benefitting from the inherent diversity of tropism afforded by the commensal virome. The company was founded in 2000 and is headquartered in Cambridge, MA. | Health Technology |
- Bolsa de valores
- Insiders
- Juan Andres
- Experiencia
